Carbios

Health careALCRBFR0011648716

RSS feed

Carbios is a French company in the field of biochemistry. It holds a number of patents in various countries.

Filings

48 filings

All Inside information36 Share buyback6 Annual financial report2 Earnings release2 Half-year financial report2

03/08/2026
Carbios provides an update on the financing of its Longlaville plant project
Inside informationFR
21/07/2026
Carbios franchit le cap des 100 batchs produits au sein de son démonstrateur industriel et étend son offre de licences au marché textile
Inside informationFrench
17/07/2026
Report on Carbios’ liquidity contract
Share buybackFR
22/06/2026
CARBIOS presents the results of its Annual General Meeting of June 18, 2026
Inside informationFR
02/06/2026
Update on the Carbios - Wankai project in China
Inside informationFR
18/05/2026
Carbios announces a change in its governance and the appointment of Benoît Grenot as Chief Executive Officer
Inside informationFR
29/04/2026
Carbios files its 2025 Universal Registration Document
Inside informationFR
17/04/2026
Carbios announces fiscal-year 2025 financial results
Inside information
17/04/2026
CARBIOS présente ses résultats annuels 2025
Earnings releaseFrench
30/03/2026
Supported by significant progress in the financing of its industrial project in France, Carbios confirms its objective to build the Longlaville plant
Inside informationFR
04/03/2026
Response to attacks against Carbios and its executives
Inside informationFR
18/12/2025
CARBIOS maintains its commitment to build the Longlaville plant and adjusts its timeline
Inside informationFR
02/12/2025
CARBIOS and Wankai New Materials sign the definitive agreement establishing a strategic partnership to the large-scale deployment of CARBIOS’s PET biorecycling technology in Asia
Inside informationFR
24/11/2025
CARBIOS signs two new multi-year commercial agreements for recycled PET with major players in the beverage industry
Inside informationFR
06/11/2025
CARBIOS and Wankai New Materials, a subsidiary of Zhink Group, are committed to the large-scale deployment of CARBIOS’ PET biorecycling technology in Asia, with the first step being the construction of a PET biorecycling plant in China.
Inside informationFR
24/10/2025
CARBIOS announces the publication of its Interim report for the first half of 2025
Half-year financial reportFR
24/09/2025
CARBIOS présente ses résultats semestriels 2025 et confirme son objectif de construction d’usine de biorecyclage du PET avec un calendrier décalé
Earnings releaseFrench
21/07/2025
CARBIOS enters the r-PET market for tire textile filaments
Inside informationFR
08/07/2025
Report on Carbios’ liquidity contract with Natixis ODDO BHF
Share buybackFR
20/06/2025
Carbios presents the results of its Annual General Meeting of 19 June 2025 and the composition of its Board of Directors
Inside informationFR
27/05/2025
CARBIOS signs its first biorecycled PET sales contracts with two global cosmetics leaders
Inside informationFR
02/05/2025
CARBIOS files its 2024 Universal Registration Document
Annual financial reportFR
21/03/2025
CARBIOS announces changes to its governance and reaffirms its strategic objectives
Inside informationFR
06/02/2025
CARBIOS is pleased that the European Commission has authorised the ‘Circular Economy’ State aid scheme
Inside informationFR
28/01/2025
In line with its press release dated 19 December 2024, which mentions the reduction of operating costs and prudent management of its strong cash position, CARBIOS today launched a project to reorganize and reduce its workforce
Inside informationFR
14/01/2025
Report on Carbios’ liquidity contract with Natixis ODDO BHF
Share buybackFR

About

ISIN: FR0011648716
Ticker: ALCRB
LEI: 969500M2RCIWO4NO5F08
Sector: Health care
Founded: 2011
Country of registration: FR
Last filing: 03/08/2026, 18:00

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive